Evercore heads into its July 22 earnings date with a fresh analyst upgrade in hand, a stock that gave back ground on Tuesday, and positioning that is remarkably unbothered for a firm heading into a key print.
The most notable event this week is a same-day UBS move: Michael Brown lifted his price target to $350 from $330 while keeping a Neutral rating. That nudge puts UBS's target just above the current price of $346.87 — not exactly a ringing endorsement, but a signal that even the skeptics are revising up. The consensus mean target sits at $381.80, implying roughly 10% upside from here. Goldman Sachs holds a Buy with a $374 target, while Morgan Stanley stays at Equal-Weight with $384. The broad Street direction has been higher since March lows: Goldman raised to $374 in April after cutting to $335 in early March, and UBS has now moved up twice since then. The trajectory of revisions is constructive, even if the ratings themselves remain split. Valuation is not cheap — the price/earnings multiple has drifted to around 17.7x and the price/book has risen about 0.33x over the past month — but neither has moved dramatically enough to signal a re-rating story in either direction. The EPS surprise score ranks in the 85th percentile, meaning Evercore has a strong track record of beating estimates, which matters as Q2 approaches.
Positioning is the least interesting part of this setup. Short interest is low — just under 3% of the free float — and has actually declined about 1.2% over the past week. Borrow cost is negligible at 0.43%, down from 0.50% a week ago. Availability is enormous, at roughly 2,771% of short interest, meaning there are nearly 28 shares available to borrow for every one already lent out. The ORTEX short score of 34.4 places Evercore firmly in the lower half of the short-pressure universe, and has barely moved in two weeks. Options are similarly calm: the put/call ratio of 0.52 is slightly above its 20-day average of 0.47, but only about 0.6 standard deviations above — nowhere near the kind of defensive clustering that signals genuine pre-earnings anxiety. None of this points to meaningful short-side conviction or options-driven hedging pressure.
The EPS momentum scores add texture to the bull case. The 90-day EPS momentum score ranks in the 76th percentile, and the EPS surprise score at the 85th percentile underlines the pattern of beats. Advisory revenues grew 23% year-over-year in the most recent quarter, well ahead of consensus. The bear case centers on compensation dynamics: the compensation ratio has been revised down to around 65% for 2025 and 62% for 2026, and bears argue that declining ratios reflect a competitive squeeze on talent costs rather than operating leverage — a debate that will run through next week's print. The ORTEX sector score sits at the 50th percentile, suggesting no particular relative advantage or disadvantage within investment banking right now.
One data point worth watching is insider activity. CFO Timothy LaLonde sold 7,808 shares on June 11 for roughly $2.7 million, the most recent trade in the filings. Earlier in February, CEO John Weinberg and founder Roger Altman each sold roughly $4.6 million of stock on the same day. A single director bought 2,000 shares in March for about $580,000. The net picture over the past 90 days is seller-dominant, though the February cluster occurred near current price levels, which reduces the interpretive significance. Among institutional holders, BlackRock added around 190,000 shares in the period to June 30, taking its stake to 9.4% — the largest single holder and a meaningful vote of confidence. FMR (Fidelity) added 414,000 shares in the same window.
Peer context is useful here. Moelis had a strong week, up 11% on the week before giving back about 3% on Tuesday. Jefferies rose over 8% on the week. Against that backdrop, EVR's 1.6% weekly gain looks modest — the stock underperformed most of its closest peers on a five-day basis, even as it pulled back 2.4% on Tuesday in line with some of the group. The July 22 Q2 earnings release is the next event that concentrates attention: the prior two prints produced next-day moves of -0.6% and -5.6% respectively, so the track record into results is asymmetrically negative on the day, even when the five-day picture recovers.
The central question into July 22 is whether advisory revenue momentum can sustain a beat after a quarter in which M&A conditions remained uneven — and whether compensation ratio guidance is trimmed further or holds at the levels the Street has already modeled.
See the live data behind this article on ORTEX.
Open EVR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
Evercore reports Q1 earnings April 29 with positioning signals cooling after a sharp rally. The stock surged 24% over the past month but gave back 5% this week, closing at $344.30. Short interest remains negligible at…
